ADIPOQ and congenital heart disease: Interestingly in patients with PHassociated with congenital heart disease, although serum levels of adiponectinare increased, adiponectin levels within endothelial cells are decreased,59 suggesting the concentration of adiponectin in specific microenvironmentsmay be important in contributing to PAH pathogenesis.